In this study, we identified two factors involved in ribosome that are over-expressed in AML patients, NOP56 and NCL. More importantly, expression of one of them, NCL, predicts AML outcome, independently of the current risk factors—age at diagnosis and cytogenetic alterations. The gene discussed is NUCLEOLIN; the disease is acute myeloid leukemia.